Skip to main content
Augmedix, Inc. (AUGX)
NASDAQ: AUGX · IEX Real-Time Price · USD
2.260
+1.344 (146.62%)
At close: Jul 19, 2024, 4:00 PM
2.270
+0.010 (0.44%)
Pre-market: Jul 22, 2024, 7:27 AM EDT

Augmedix Revenue

Augmedix had revenue of $48.70M in the twelve months ending March 31, 2024, with 45.04% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.47M with 39.91% year-over-year growth. In the year 2023, Augmedix had annual revenue of $44.86M with 45.01% growth.

Revenue (ttm)
$48.70M
Revenue Growth
+45.04%
P/S Ratio
2.27
Revenue / Employee
$34,055
Employees
1,430
Market Cap
110.67M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202344.86M13.92M45.01%
Dec 31, 202230.93M8.77M39.56%
Dec 31, 202122.17M5.68M34.47%
Dec 31, 202016.48M2.38M16.84%
Dec 31, 201914.11M3.29M30.44%
Dec 31, 201810.82M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karyopharm Therapeutics 140.46M
Journey Medical 80.00M
TELA Bio 63.15M
BrainsWay 34.26M
Elutia 28.99M
Adagene 18.11M
Armata Pharmaceuticals 4.70M
I-Mab 3.90M
Revenue Rankings

AUGX News

More News